BROWSE ALL ARTICLES BY TOPIC
RELATED ITEMS
EXCLUSIVE ONLINE ARTICLES
Listing articles 11 to 20 of 59
Meeting: Tips for Myositis Management
Differentiating between subgroups of myositis is a diagnostic challenge for physicians, but using some guiding principles can be helpful,
Meeting: Panel Addresses Drug Safety Issues in Rheumatology Products
Black box warnings, TNF inhibitors, and tofacitinib discussed
Meeting: Tackle Tricky Lung Complications in Connective Tissue Disease
Guidance for diagnosing and treating interstitial lung disease complications
News: First Annual Rheumatoid Awareness Day to Be Held February 2
New day of action and outreach aims to spread awareness of rheumatoid arthritis
News: Make Critical Electronic Health Record Decisions Now to Avoid Penalties and Maximize Incentives
Rheumatology practices of all sizes are considering the most cost-efficient and effective ways to achieve Meaningful Use.
News: Aggressive Treatment of Inflammation Prevents Vision Loss in Patients with JIA-related Uveitis
A new study confirms that the use of immunosuppressive drugs is associated with a reduced risk of vision loss in patients with juvenile idiopathic arthritis-related uveitis.
News: New Hydrogel May Offer Promising Osteoarthritis Treatment
A new hydrogel that can be stretched and is self-healing might become an effective ligament repair option in osteoarthritis (OA).
Features: Gene to Block TNF Linked to Multiple Sclerosis but not Rheumatoid Arthritis
A single nucleotide polymorphism (SNP) in the TNFRSF1A gene encoding the receptor for tumor necrosis factor (TNF) 1 is associated with multiple sclerosis (MS) but not rheumatoid arthritis (RA) or other autoimmune conditions.
News: Survivin Essential for the Maturation of Antigen Presenting Cells in Rheumatoid Arthritis Patients
In patients with RA, survivin is essential for the survival of leukocytes as they differentiate and mature into dendritic cells, thereby raising it as a potential therapeutic target.
Features: Molecular Analysis Reveals Potential Treatment Window for Systemic Juvenile Idiopathic Arthritis
In patients with simultaneous systemic and arthritic components of systemic juvenile idiopathic arthritis (SJIA), these components appear to be related mechanistically. Moreover, the inflammatory pathways of SJIA appear to be distinct from those seen in polyarticular JIA.
